Cantourage Group SE (ETR:HIGH)
5.40
-0.24 (-4.26%)
At close: Aug 5, 2026
Cantourage Group SE Market Cap
Cantourage Group SE has a market cap or net worth of €69.33 million as of August 5, 2026. Its market cap has increased by 38.31% in one year.
Market Cap
69.33M
Enterprise Value
69.19M
Revenue
3.91M
Ranking
n/a
PE Ratio
548.27
Stock Price
€5.40
ChartMarket Cap Chart
Since November 11, 2022, Cantourage Group SE's market cap has decreased from 193.56M to 69.33M, a decrease of -64.18%. That is a compound annual growth rate of -24.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 69.33M | 64.01% |
| Dec 30, 2025 | 42.27M | -33.53% |
| Dec 30, 2024 | 63.60M | -25.41% |
| Dec 29, 2023 | 85.26M | -49.22% |
| Dec 30, 2022 | 167.91M | -13.25% |
| Nov 11, 2022 | 193.56M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 63.63B |
| Bayer Aktiengesellschaft | 47.40B |
| Siemens Healthineers AG | 43.53B |
| Fresenius SE & Co. KGaA | 25.22B |
| LIMES Schlosskliniken AG | 163.87M |
| Viromed Medical AG | 159.38M |
| Heidelberg Pharma AG | 121.64M |
| DocCheck AG | 58.35M |